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As children with cardiac disease grow older, atrial flutter 
becomes more prevalent. A collaborative study was per•
formed in 19 institntions to determine the clinical char•
acteristics of these children and the factors affecting 
prognosis. There were 380 patients with one or more 
electrocardiographically documented episodes of atrial 
flutter that first occurred between ages 1 and 2S years 
(mean age at onset 10.3). Episodes of flutter continued 
to occur for a mean of 2.5 years after the onset. Of the 
380 patients, 60% had repaired congenital heart disease. 
13% palliated congenital heart disease, 8% unoperated 
congenital heart disease, 8% an otherwise normal heart, 
6% cardiomyopathy, 4% rheumatic heart disease and 
2 % other lesions. 
Overall, drugs were effective in eliminating atrial flutter 
in 58% of patients; specifically, amiodarone and digoxin 
plus quinidine were effective in 53%, digoxin alone in 
44% and propranolol in 21 %. Amiodarone was effective 
in seven (78%) of nine patients. Corrective surgery was 
Advances in surgical treatment of congenital heart disease 
and medical therapy have allowed children with an abnormal 
heart to live into adolescence and adulthood. One of the 
apparent consequences of these conditions is an increased 
incidence of atrial flutter. Because each hospital has rela•
tively few cases, we performed a collaborative study in•
volving 19 institutions to determine the clinical character•
istics of children with atrial flutter and the factors that affect 
the prognosis in terms of response to treatment and eventual 
survival. 
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performed after the onset of atrial flutter in 66 patients; 
in 52 % the atrial flutter was easier to control or it re•
solved and in only 4% it was worse. At follow-up (mean 
6.5 years), 83% of the patients were alive (49% without 
atrial flutter and 34% with atrial flutter) and 17% died 
(10% suddenly, 6% of nonsudden cardiac cause and 1 % 
of noncardiac cause). Cardiac death occurred in 20% 
of those for whom an effective drug could not be found 
to eliminate atrial flutter compared with S% of those 
who were treated with an effective drug (p < 0.001). 
In conclusion: 1) The goal of medical therapy should 
be to eliminate episodes of atrial flutter because the chance 
of sudden death is four times higher in patients who 
continue to have episodes of atrial flutter. 2) If the hemo•
dynamic results can be improved with an operation, it 
should be performed because possible amelioration of 
flutter outweighs the risk of worsening flutter by more 
than 10 to 1. 
(J Am Coil CardioI1985;6:87I-S) 
Methods 
Definition. Atrial flutter was defined (1) as the presence 
of flutter waves on the surface electrocardiogram. In chil•
dren, the atrial rate was not specified in the definition be•
cause it can vary from 200 to 500/min depending on age 
and clinical situation. A patient was included if he or she 
had one or more clinical episodes of electrocardiographi•
cally documented atrial flutter. The patient was not included 
if the only episode of atrial flutter was noted in the cardiac 
catheterization laboratory. Only children with the onset of 
atrial flutter between 12 months and 25 years of age were 
included. The lower limit was chosen to exclude infants and 
neonates with congenital atrial flutter (2). It was recognized 
that certain patients with early repair of congenital heart 
disease and atrial flutter occurring early postoperatively might 
be excluded because of this criterion. 
Data collection. The 19 investigators of the Pediatric 
Electrophysiology Society were asked to collaborate. The 
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investigators and institutions are shown in the appendix; 
those submitting the largest number of patients are also listed 
as coauthors. (The valuable collaboration of the other in•
vestigators is gratefully acknowledged.) We found 380 pa•
tients that met the previously mentioned criteria. Standard•
ized forms were distributed and patients were identified by 
number. In addition to demographic variables, the following 
were recorded: I) Cardiac diagnosis (usually determined on 
the basis of cardiac catheterization). 2) Surgical procedures 
before the onset of atrial flutter and age at the procedure. 
3) Age at onset of atrial flutter. 4) Symptoms with the first 
episode. 5) Left atrial dimension on M-mode echocardio~ 
gram. (The atrial dimension and body weight were given 
and compared with a single set of normal values (31). Then 
a ratio of the patient's value to the upper limit of normal 
was calculated, so that any value greater than 100% was 
above normal. Echocardiograms were only included if taken 
during sinus rhythm. Echographic dimensions were not cal•
culated for patients after the Mustard or Senning operation. 
6) Left and right atrial mean pressures during cardiac cath•
eterization (measurements were included only if taken dur•
ing sinus rhythm). 7) Response to long-term drug treatment; 
re!;ponse was defined as abolition of episodes of atrial flutter 
for at least I year and continued ab!;ence throughout the 
duration of follow-up by clinical history, routine electro•
cardiogram and repeat ambulatory electrocardiographic ex•
amination. Continued presence of atrial flutter, despite a 
controlled ventricular respon!;e was considered as drug fail•
ure. Using this definition, the response to each drug or drug 
combination was recorded; the response to acute treatment 
Table 1. Cardiac Diagnosis in 380 Patients 
D-transposition of great arteries 
Complex congenital lesions 
Atrial septal defect 
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was not recorded. 8) Presence of a pacemaker. 9) Cardiac 
surgery after the onset of atrial flutter and age. 10) Quali•
tative response of atrial flutter after the operation in terms 
of whether the flutter was eliminated, easier or more difficult 
to control. 11) Follow-up interval. 12) Total duration of 
episodes of atrial flutter. 13) Follow-up status (alive: with 
or without flutter, with or without treatment; or dead: sud•
den, nonsudden cardiac, noncardiac death). 
Statistical methods. Interrelations between two contin•
uous variables were determined by Student's t test and among 
three or more variables by analysis of variance, followed 
by t tests using Bonferroni's modification (4). Comparison 
between variables distributed into categories was made by 
chi-square analysis. Statistical significance was inferred if 
the probability level was le!;s than 0.05. 
Results 
Cardiac diagnosis (Table 1). Among the 380 patients, 
seven diagnoses predominated, accounting for more than 
75% of the patients. These were the only diagnoses present 
in 5% or more of the patients. [n descending order of prev•
alence they were: 1) D-transposition of the great arteries; 
2) complex congenital heart disease (for example, single 
ventricle with or without pulmonary stenosis); 3) atrial septal 
defect (80% ostium secundum, 10% ostium primum. 10% 
sinus venosus); 4) pulmonary stenosis (with or without ven•
tricular septal defect), pulmonary atresia (with or without 
ventricular septal defect) and tetralogy of Fallot (grouped 
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insufficiency); 5) normal heart without evidence of cardio•
myopathy (from physical examination, chest X-ray film, 
usually echocardiogram and usually cardiac catheterization); 
6) congestive cardiomyopathy; and 7) complete atrioven•
tricular (A V) canal. The other diagnoses are shown in Table 
1. 
Considering these diagnoses by categories, 60.4% of 
patients had repaired congenital heart disease, 13.3% pal•
liated congenital heart disease, 7.6% unoperated congenital 
heart disease, 7.6% a normal heart, 6.2% congestive car•
diomyopathy, 1.9% unoperated rheumatic heart disease, 1.6% 
operated rheumatic heart disease and 1.4% other lesions. 
Cardiac surgery before onset of atrial flutter (Table 
2). Of the 380 patients, 284 (75%) had had at least one 
cardiac operation at a mean age of 5.2 years; 75 (20%) had 
had a second operation before the onset of atrial flutter. The 
five most commonly performed operations (either as a first 
or second operation) were: Mustard or Senning (27.6%); 
Blalock-Hanlon (16.1 %); repair of atrial septal defect (11.1 %); 
repair of pulmonary atresia/tetralogy of Fallot (7.9%) and 
aorticopulmonary anastomosis (6.6%). The relation of the 
most common congenital cardiac diagnoses to the type of 
surgery is shown in Table 2. Almost all patients had had 
cardiac surgery and in 89% the operation involved intra•
cardiac repair of the defect. The type of operation shown 
in Table 2 can generally be ascertained from the lesion. The 
majority of complex repair operations involved a Mustard 
operation, and the palliative operations were either pul•
monary artery banding or aorticopulmonary anastomosis. 
In tricuspid atresia, the repair was made by the Fontan 
procedure, and palliation was an aorticopulmonary 
anastomosis. 
Age at onset of atrial flutter. The mean age (± SEM) 
at onset of atrial flutter was 10.3 ± 0.3 years (range 1.1 
to 25). The ages were approximately equally distributed 
throughout childhood. In the patients in whom atrial flutter 
developed after an operation, the mean postoperative inter•
val was 3.6 years (range 0 [on the day of operation] to 
19.8). In 23% of the patients, atrial flutter developed within 
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the first 2 weeks after surgery (Fig. 1). In the majority of 
cases, atrial flutter developed between 1 and 5 years after 
surgery. 
Considering the diagnosis, patients who were youngest 
at onset of flutter were those with D-transposition of the 
great arteries (5.5 ± 0.3 years), followed by those with an 
atrial septal defect (10.3 ± 0.8 years) , normal heart 
(12.8 ± 0.7 years), pulmonary atresia/tetralogy of Fallot 
(12.3 ± 1.0 years), cardiomyopathy (14.0 ± 1.0 years) 
and tricuspid atresia (14.9 ± 1.8 years). Analysis of var•
iance indicated a significant difference among the patients, 
and individual comparisons between the youngest and oldest 
age groups were significantly different (p < 0.01). Because 
the postoperative intervals of these lesions were not signif•
icantly different, the difference in the age of onset reflected 
the younger age of operation in transposition and the older 
age in tricuspid atresia. 
Symptoms with first episode of atrial flutter. A report 
of the presence or absence of symptoms with the first episode 
of atrial flutter was available in 364 patients: 30% were 
asymptomatic, 28% had dyspnea or other symptoms of 
congestive heart failure, 24% had palpitation, 9% had syn•
cope and 8% had presyncope with dizziness. In three pa•
tients (1 %) without previous episodes of atrial flutter, it was 
found during attempted resuscitation from sudden death. 
Syncope was significantly more common in patients with 
a normal heart (29%) and in those with the Wolff-Parkinson•
White syndrome (50%) compared with the remainder of the 
patients (6.9%) (p < 0.001). Overall symptoms were sig•
nificantly more common with onset after 5 years of age 
(73%) compared with a younger age of onset (59%) (p < 
0.05). Syncope was significantly less common at younger 
than 5 years of age (3 versus 11 % of all patients, p < 0.01) 
and congestive heart failure was more common at younger 
than 5 years of age (39 versus 24% of all patients, p < 
0.01). 
Anatomy and hemodynamics. Echocardiogram. The 
left atrial dimension as assessed by M-mode echocardiogram 
was abnormal, exceeding the upper limit of normal for age 
Table 2. Surgical Procedures in 281 Patients Before Onset of Flutter 
Total 
No. of Repair Palliation Operation 
Patients (%) (%) (%) 
D-transposition of great arteries 78 100 0 100 
Complex congenital lesions 68 59 35 94 
ASD 47 87 0 87 
ToF 30 93 7 100 
AV canal 19 80 4 84 
TAPVR 18 100 0 100 
VSD 12 92 8 100 
Tricuspid atresia 9 56 44 100 
ASD = atrial septal defect; A V = atrioventricular; T APVR = total anomalous pulmonary venous return; 
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Figure 1. Postoperative interval of 279 patients (PTS) in whom 
atrial flutter began after cardiac surgery. In 23%, atrial flutter 
occurred in the immediate postoperative (POST-OP) period. In the 
remaining patients, it occurred 1 month or more after surgery (in 
the majority between 1 and 5 years after surgery). 
in 64% of the 134 patients who had an echocardiogram; in 
24%, the left atrial dimension was greater than 150% of the 
upper limit of normal. 
Cardiac catheterization. This procedure had been per•
formed in 256 patients. The left atrial mean pressure av•
eraged 10.6 ± 0.4 mm Hg (range 1 to 40). In 62% of the 
patients, the left atrial mean pressure was 10 mm Hg or 
less; in only 10% was it greater than 20 mm Hg. The right 
atrial mean pressure averaged 7.0 ± 0.3 mm Hg (range 0 
to 24). In 75%, the right atrial mean pressure was 8 mm 
Hg or less; in only 7% was it greater than 15 mm Hg. 
Drug treatment at onset of atrial flutter. The majority 
of patients (60%) were not receiving drug treatment at the 
time of the first episode of atrial flutter. Almost all who 
were receiving treatment (93% of the remaining 40%) had 
digoxin prescribed either for preexisting congestive heart 
failure or as prophylaxis against atrial flutter. Twice as many 
patients who were not receiving digoxin had syncope with 
their first episode compared with those who were (12 versus 
6%, p < 0.05). 
Drug efficacy in long-term treatment of atrial flutter 
(Fig. 2). One or more drugs were used to treat atrial flutter 
in 347 patients. The remaining 33 patients (9%) received 
no long-term treatment. The overall success rate of any drug 
treatment or combination of drugs in completely eliminating 
episodes of atrial flutter was 58%. The number of times that 
a drug or drug combination was effective was divided by 
the number of times that a drug or drug combination was 
tried, and a percent was calculated. Of the conventional 
antiarrhythmic drugs, the most effective treatment (53% of 
the patients) was the combination of digoxin with a type I 
antiarrhythmic drug such as quinidine or procainamide. Dig•
oxin alone was successful in 44% of the patients to whom 
it was given. Overall, the most effective drug was amio•
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Figure 2. Long-term drug efficacy in 347 patients. The percent 
(%) effectiveness of each of the drugs or drug combinations is 
shown. The first column shows any drug that is effective. The 
other columns show each of the drugs or drug combinations. The 
number of patients in whom the drug or drug combination was 
tried is shown below the name of the drug. AMIO = amiodarone; 
DIG = digoxin; DIL = dilantin (phenytoin); P = propranolol; 
Tl = type I antiarrhythmic drug (quinidine, procainamide, di•
sopyramide); V = verapamil. 
cessful in seven. Amiodarone was significantly (p < 0.05) 
more effective than digoxin alone, but, because of the small 
sample size, comparison with digoxin and a type I agent 
did not achieve statistical significance. 
Propranolol, whether used alone or in combination with 
digoxin, was the least effective of the conventional drugs. 
It was significantly (p < 0.01) less effective than digoxin 
alone or in combination with a type I drug. Finally, vera•
pamil was only given to two patients. Although it was ef•
fective in controlling the ventricular rate, it did not eliminate 
episodes of atrial flutter in either patient and, therefore, was 
not effective by our criteria. 
The effectiveness of a drug was generally not dependent 
on the type of underlying cardiac disease. Drug effective•
ness ranged from 50 to 70% in patients with D-transposition 
of the great arteries, complex congenital heart disease, atrial 
septal defect, tetralogy of Fallot and normal heart. However, 
drug effectiveness was lower in patients with cardio•
myopathy (43%) and total anomalous pulmonary venous 
return (31%) and higher in those with tricuspid atresia (89%). 
These three groups were significantly different from each 
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Table 3. Response to Surgery After Onset of Atrial Flutter (AF) in 52 Patients 
No. of AF Resolved or No Change Worse 
Patients Fewer Episodes (%) (%) (%) 
Kent bundle 4 
ASD closure 4 
Reclosure of VSD (ToF) 11 
Mustard (complex) 3 
TAPVR 3 
Repeat Mustard 5 
Mitral valve 14 
Tricuspid valve 8 
Abbreviations as in Table 2. 
Surgery after onset of atrial flutter (Table 3). In 66 
patients, surgery was perfonned after the onset of atrial 
flutter. The most commonly perfonned procedures were: 
mitral valve surgery (either mitral anuloplasty, valvotomy 
or valve replacement) in 14 patients (21 %), reoperation to 
close a ventricular septal defect in 11, tricuspid surgery in 
8, atrial septal defect closure (first operation) in 4, reoper•
ation for Mustard repair in 5 and ventricular septal defect 
closure (first operation) in 5. In 52% of these patients, the 
atrial flutter either resolved completely without the need for 
medication after operation or the flutter responded to med•
ication that had been ineffective before surgery. Only 6% 
of the patients with atrial flutter before the operation had 
episodes of flutter increase after the operation. 
There were differences in success depending on the type 
of operation (Table 3). The most successful operation for 
control of atrial flutter was ablation of a bundle of Kent. In 
the other operations, hemodynamics were changed. All 11 
patients operated on for a ventricular septal defect had te•
tralogy of Fallot; the 3 patients who had a Mustard operation 
after the onset of atrial flutter had previously palliated com•
plex cyanotic congenital heart disease. In two of these three 
patients, the atrial flutter lessened. However, among the five 
patients with reoperation for a Mustard repair, only two had 
a lessening of atrial flutter. Operation on the mitral or tri•
cuspid valve was the least successful in ameliorating epi•
sodes of atrial flutter. 
Follow-Up 
Follow-up interval (Fig. 3). Follow-up study was done 
for 357 of the 380 patients; 297 (83%) were alive at an 
average follow-up time of 6.5 years. The follow-up interval 
ranged from 1 month to 22.3 years. Sixty patients (17%) 
had died an average of 2.4 years after the first episode of 
atrial flutter (0 to 13 years after the first episode). The 
distribution of survivors is significantly different (p < 0.01) 
from that of nonsurvivors, with 88% of the deaths occurring 
within 5 years of the onset of atrial flutter. This implies that 
the time to death is independent of the overall duration of 
follow-up. 
100 0 0 
75 25 0 
73 27 0 
67 33 0 
67 33 33 
40 6C 0 
35 65 0 
24 38 
Duration of flutter (Fig. 4). The average duration of 
episodes of atrial flutter was 2.5 years. In 33% of the pa•
tients, flutter occurred only once and in an additional 21 %, 
the duration of flutter was 1 year or less. In the remaining 
56% of patients, episodes of atrial flutter continued for more 
than 1 year; approximately half of these patients were still 
having episodes of atrial flutter at the time of follow-up 
study. Therefore, the duration of episodes of flutter is a 
minimal figure. 
Final status (Table 4). The final status was detennined 
in 368 of the 380 patients; 83.4% of the patients were alive 
at an average age at follow-up of 14.5 years (range 1.2 to 
38.4). The majority of these patients (48.6%) were not 
having episodes of atrial flutter; however, in 34.8% atrial 
flutter continued despite treatment. 
The New York Heart Association functional class was 
available for 278 of the patients who were alive at follow•
up; 67% were in class I, 27% in class II and 6% in class 
III or IV. At follow-up, 16.6% of the patients had died at 
an average age of 15.5 years (range 2 to 21). The vast 
majority of these deaths were sudden. Four variables are 
worthy of mention with respect to final status: diagnosis, 
left atrial dimension, presence of a pacemaker and drug 
effecti veness. 
Figure 3. Follow-up interval in 357 patients. The patients (PTS) 
known to be alive at follow-up (n = 297) (stippled boxes) are 
shown separately from those that had died (n = 60) (striped 
boxes). 
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Figure 4. Duration of atrial flutter in 350 patients. In 33% of the 
patients, atrial flutter occurred only once. The total height of the 
other bars represents the percent (%) of patients (PIS) with their 
duration of flutter at last follow-up indication. The stippled boxes 
show those patients in whom atrial flutter was continuing at the 
time of follow-up and in whom, therefore, the duration of flutter 
is at a minimum. 
Effect of cardiac diagnosis (Table 5). The final status 
differed with the type of underlying cardiac disease. The 
overall death rate was significantly higher (p < 0.01) in 
patients with cardiomyopathy and complex congenital heart 
disease than in other patient groups. No death was reported 
in patients with a normal heart, tricuspid atresia or total 
anomalous pulmonary venous return. The rate of sudden 
death was significantly higher in patients with complex con•
genital heart disease than in other groups (p < 0.05); the 
rate of nonsudden death was higher in patients with cardio•
myopathy (p < 0.025). The spontaneous resolution of atrial 
flutter without need for medical therapy occurred in ap•
proximately 20% of all cases. Resolution of flutter was 
significantly more frequent in patients with atrial septal de•
fect (41 %) than in those with cardiomyopathy (4%) or A V 
canal (5%) (p < 0.025). 
Effect of echocardiographic left atrial dimension (Ta•
ble 6). With each increase in left atrial dimension, the in•
cidence of sudden and nonsudden death increased. This was 
especially significant when those patients with left atrial 
dimension greater than 150% of the upper limits of normal 
were compared with the rest (p < 0.025). However, in those 
with a smaller left atrium, the atrial flutter was more likely 
to resolve spontaneously without the need for medication: 




No Rx 19.4 
Flutter 
Rx 30.3 




Nonsudden cardiac 6.2 
Noncardiac 0.3 
No Rx = not receiving medical treatment for atrial flutter; Rx 
receiving medical treatment for atrial flutter. 
Table 5. Final Status of 368 Patients 
Cardiac Alive Sudden 
Diagnosis (%) Death (%) 
D-TGA 87 10 
Complex 66 25 
ASD 98 2 
ToF 86 7 
Normal 100 0 
Congestive 61 13 
cardiomyopathy 
TAPVR 100 0 
TA 100 0 













D-TGA = D-transposition of great arteries. Other abbreviations as in 
Table 2. 
59% of those with a left atrial dimension less than the upper 
limit of normal had complete resolution of atrial flutter com•
pared with 27% of those with left atrial dimension greater 
than the upper limit of normal. 
Effect of pacemaker. Seventeen percent of the patients 
had pacemaker implantation. However, although the inci•
dence of sudden death in those with a pacemaker tended to 
be lower than in those without one (7 versus 11 %), this 
difference was not statistically significant. It was not known 
whether pacemaker malfunction was present in any patient 
who died suddenly. Furthermore, the incidence of success•
ful drug treatment was not different in those with or without 
a pacemaker. 
Effect of successful drug treatment. The incidence of 
sudden death in patients without effective control of atrial 
flutter was 20% (18 of 91) compared with 5% (8 of 169) 
among those in whom atrial flutter could be eliminated 
(p < 0.001). The same was true for episodes of nonsudden 
cardiac death: 12% in those without effective control com•
pared with 5% of those in whom flutter could be eliminated 
(p < 0.025). 
Discussion 
Risk of atrial flutter. In this study, 94% of the patients 
had an abnormal heart and, of these, 80% had had prior 
Table 6. Effect of Left Atrial Dimension on Final Status 
Sudden Nonsudden 
No. of Alive Death Cardiac Death 
Patients (%) (%) (%) 
LA dimension 
:5100% 48 92 2 5 
101 to 150% 53 87 4 9 
>150% 29 69 10 21 
P <0.025 
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cardiac surgery. Although this study was not designed to 
ascertain the incidence of atrial flutter in the general pop•
ulation, certain groups of patients seemed to have a higher 
incidence of atrial flutter not commensurate with the inci•
dence of that type of cardiac disease. 
In the first group are patients who have undergone the 
Mustard or Senning operation for transposition of the great 
arteries. The incidence of atrial flutter in long-term follow•
up study of patients after the Mustard operation varies from 
5 to 25% (5,6). The incidence of arrhythmias after the 
Senning operation seems to be similar (7). In these patients, 
atrial flutter is probably related to the large number of atrial 
suture lines and direct sinus node damage. After the Mustard 
operation, atrial flutter is rare without coexistent sinus 
bradycardia (8). It is possible that if sinus node damage can 
be prevented, atrial flutter will be reduced. Certain groups 
(9,10), reporting a low incidence of both atrial flutter and 
sinus bradycardia after the Mustard operation, have attrib•
uted this decrease to meticulous care and retraction of the 
sinus node area during surgery and to suture placement. 
Despite such care, however, many centers (11) have found 
atrial flutter to be a persistent problem. 
In the second group of patients are those who had the 
Blalock-Hanlon operation. In our study, a small number of 
patients had this procedure alone. Nonetheless, 40% of the 
postoperative patients with atrial flutter who underwent a 
MustardiSenning operation had a preceding Blalock-Hanlon 
operation. Because this is a much greater number than the 
percent of preceding Blalock-Hanlon operations among all 
patients who undergo the Mustard procedure (12), it may 
represent an independent effect. 
In the third high risk group for atrial flutter are patients 
who underwent repair of an ostium secundum atrial septal 
defect. Bricker et al. (13) found an incidence of atrial flutter 
of 3% during 5 years of follow-up. The mechanism could 
involve a large area of atrial scar in the region of the patch 
or could result from sinus node damage at the time of surgery . 
In the fourth high risk group are those who underwent 
repair of tetralogy of Fallot with the sequel of tricuspid 
insufficiency. The incidence of tricuspid insufficiency after 
repair of tetralogy of Fallot is exceedingly low (14,15). 
Because almost all patients with atrial flutter in this series 
who had tetralogy of Fallot also had tricuspid insufficiency, 
this probably represents a high risk group. 
In the fifth high risk group are those with congestive 
cardiomyopathy. The incidence of atrial flutter in patients 
with cardiomyopathy is approximately 10% (16). In these 
patients, we believe that the atrial flutter is probably sec•
ondary to the atrial dilation as a cause of the cardio•
myopathy. This is not the case with certain forms of chronic 
supraventricular tachycardia (atrial ectopic focus [17], 
"atypical" AV node reentrant supraventricular tachycardia 
[18] and Wolff-Parkinson-White syndrome [19]) in which 
the tachycardia precedes the onset of cardiomyopathy and 
resolution of the cardiomyopathy causes normalization of 
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cardiac size and function. With atrial flutter, the cardio•
myopathy precedes the arrhythmia and control of the ar•
rhythmia does not normalize the heart. 
The final high risk group for development of atrial flutter 
appears to be those with echocardiographic left atrial di•
mension greater than 150% of the upper limit of normal. 
From our data, the left atrial size, not the left atrial pressure, 
is more highly associated with atrial flutter. In this study, 
data were not available on right atrial size. It is possible 
that the right atrial data would be similar to that from the 
left atrium, implicating size rather than pressure, since rel•
atively few patients with atrial flutter had a high right atrial 
mean pressure. 
Risk of death: surgical and medical therapy. The most 
important implications of this study concern surgical and 
medical therapy. We have found that surgery after the onset 
of atrial flutter can eliminate or improve the arrhythmia in 
more than half the patients in whom it is performed. In 
patients who undergo operation for hemodynamic indica•
tions (that is, repair of an atrial septal defect), it is possible 
that an improvement in the hemodynamics reduces the pro•
pensity for atrial flutter. In patients with congenital heart 
disease who have supraventricular tachycardia and undergo 
hemodynamic repair, the incidence of supraventricular 
tachycardia decreases (20). There may be a similar effect 
of hemodynamics in both atrial flutter and supraventricular 
tachycardia. 
For those with Wolff-Parkinson-White syndrome and atrial 
flutter, the Kent bundle does not participate directly in the 
atrial flutter. However, it is possible that with ablation of 
the Kent bundle, early premature ventricular beats will not 
conduct retrogradely to the atrium, perhaps eliminating a 
method of initiation of atrial flutter. Alternatively, if epi•
sodes of supraventricular tachycardia due to the Kent bundle 
are eliminated, the episodes of tachycardia might then not 
induce atrial flutter. 
Sudden death. In this study, we demonstrated that elim•
ination of episodes of atrial flutter with successful medical 
treatment was associated with a significantly lower mortality 
rate from sudden and nonsudden cardiac death than when 
therapy was not given or was ineffective. The higher risk 
of death was present whether or not the ventricular rate was 
"controlled." It is not possible in most patients to determine 
with assurance that atrial flutter resulted in sudden death. 
However, three of our patients with episodes of atrial flutter 
were undergoing ambulatory monitoring at the time of sud•
den death. In two, the ventricular rate accelerated because 
of 1 : 1 A V conduction and in one, the ventricular rate slowed 
as a result of progressive A V block. The additional obser•
vation that four patients in this series died suddenly with a 
pacemaker implanted suggests that tachyarrhythmias them•
selves may be an important direct cause of sudden death. 
Nonsudden cardiac death. Atrial flutter may be more 
difficult to eliminate in patients with severe congestive heart 
failure. Alternatively, it may be that episodes of atrial flutter 
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contribute to congestive heart failure, causing further car•
diac decompensation. Exercise tolerance of patients during 
atrial flutter is decreased compared with that in the same 
patients during sinus rhythm (21). It is possible, therefore, 
that during any period of physical activity, the patient with 
continued atrial flutter has a suboptimal cardiac output lead•
ing to further cardiac dilation. The episodic cardiac dilation 
can possibly lead to valvular insufficiency, hastening the 
process of nonsudden death from congestive heart failure. 
Conclusions and Recommendations 
1) Certain groups of patients are at high risk for devel•
opment of atrial flutter. In these patients, especially those 
with atrial dilation, prophylactic treatment with digoxin may 
be indicated, since the incidence of syncope is significantly 
reduced in patients taking digoxin. 
2) In a patient who has had an episode of atrial flutter, 
the goal of medical therapy should be to eliminate such 
episodes (rather than allowing atrial flutter to continue with 
a "controlled" ventricular rate) since the likelihood of sud•
den death is four times higher in patients who continue to 
have episodes of atrial flutter. 
3) Surgery after the onset of atrial flutter may eliminate 
the arrhythmia. We found that possible amelioration of atrial 
flutter by subsequent surgery outweighed the risk of wors•
ening the flutter by 10 to 1. 
Appendix 
Pediatric Electrophysiology Society Collaborating Investiga•
tors and Participating Institutions 
Celia 1. Flinn, MD, Cardinal Glennon Memorial Hospital. St. Louis, 
Missouri; lohn F. Keane, MD, Children's Hospital Medical Center, Bos•
ton, Massachusetts; Winston E. Gaum, MD, Children's Hospital Medical 
Center, Cincinnati, Ohio; Karen S. Kuehl, MD, Children's Hospital Na•
tional Medical Center, Washington, D.C.; Victoria L. Vetter, MD, Chil•
dren's Hospital of Philadelphia, Pennsylvania; Allan J. Hordof, MD, 
Columbia University, Babies Hospital, New York, New York; Carl H. 
Gumbiner, MD, Fitzsimmons Army Medical Center, Denver, Colorado; 
Peter 1. Baron, MD, Good Samaritan Hospital, Phoenix, Arizona; Peter 
S. Hesslein, MD, Hospital For Sick Children, Toronto, Ontario, Canada; 
Rae-Ellen W. Kavey, MD, State University of New York, Syracuse, New 
York; Co-burn 1. Porter, MD, Texas Children's Hospital, Houston, Texas; 
Paul Stanger, MD, University of California, San Francisco, California; 
Margreet Bink-Boelkens, MD, University of Groningen, Groningen, The 
Netherlands; Grace S. Wolff, MD, University of Miami, Miami, Florida; 
Macdonald Dick II, MD, University of Michigan, Ann Arbor, Michigan; 
lohn D. Kugler, MD, University of Nebraska, Omaha, Nebraska; Chen•
Yu Miao, MD, William H. Neches, MD, University of Pittsburgh, Pitts•
burgh, Pennsylvania; Alfonso Casta, MD, University of Texas Medical 
Branch, Galveston, Texas; Edgar A. Newfeld, MD, University of Texas, 
Southwestern, Dallas, Texas. 
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